1 |
CHEN W, ZHENG R, ZHANG S, et al. Cancer incidence and mortality in China, 2013 [J]. Cancer Lett, 2017, 401: 63-71.
|
2 |
HERRICK D B, LIN B, PETERSON J, et al. Notch1 maintains dormancy of olfactory horizontal basal cells, a reserve neural stem cell [J]. Proc Natl Acad Sci U S A, 2017, 114 (28): E5589-E5598.
|
3 |
TEOH S L, DAS S. Notch signalling pathways and their importance in the treatment of cancers [J]. Curr Drug Targets, 2018, 19 (2): 128-143.
|
4 |
QIAN X Q, TANG S S, SHEN Y M, et al. Notch1 affects chemo-resistance through regulating epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer cells [J]. Int J Med Sci, 2020,17(9):1215-1223.
|
5 |
PU Z, YANG F, WANG L, et al. Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer [J]. J Drug Target, 2020, 28: 1-13.
|
6 |
FAHIM Y, YOUSEFI M, IZADPANDAH M H,et al. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma [J]. Mol Cell Biochem, 2020, 474 (1/2): 181-188.
|
7 |
WEIJZEN S, RIZZO P, BRAID M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells [J].Nat Med,2002,8(9):979-986.
|
8 |
YANG Y L, JABLONS D, YOU L. An alternative way to initiate Notch1 signaling in non- small cell lung cancer[J].Transl Lung Cancer Res,2014,3(4): 238-241.
|
9 |
ZOU B, ZHOU X L, LAI S Q, et al. Notch signaling and non-small cell lung cancer [J]. Oncol Lett, 2018, 15 (3): 3415-3421.
|
10 |
YUAN X, WU H, XU H, et al. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis [J]. Sci Rep, 2015, 5: 10338.
|
11 |
ELIASZ S, LIANG S, CHEN Y, et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway [J]. Oncogene, 2010, 29 (17): 2488-2498.
|
12 |
HUANG S, LI C, HUANG J, et al. LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a [J]. BMC Pulm Med, 2020, 20 (1): 110.
|
13 |
TANG Y Q, JAGANATH I B, MANIAM R, et al. Phyllanthus spp. exerts anti-angiogenic and anti-metastatic effects through inhibition on matrix metalloproteinase enzymes [J]. Nutr Cancer, 2015, 67 (5):783-795.
|
14 |
PITTAYAPRUEK P, MEEPHANSAN J, PRAPAPAN O, et al. Role of matrix metalloproteinases in photoaging and photocarcinogenesis [J]. Int J Mol Sci, 2016, 17 (6): 868.
|
15 |
HAFEEZ B BIN, ADHAMI V M, ASIM M, et al. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator [J]. Clin Cancer Res, 2009, 15 (2): 452-459.
|
16 |
SADREMOMTAZ A, KOBARFARD F, MANSOURI K,et al.Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2[J].J Recept Signal Transduct Res, 2018, 38 (5/6): 432-441.
|
17 |
ZANG M, HU L, ZHANG B, et al. Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer [J]. Biochem Biophys Res Commun, 2017, 490 (3): 913-919.
|
18 |
TSUBAKIHARA Y, MOUSTAKAS A. Epithelial-mesenchymal transition and metastasis under the control of transforming growth factor β [J]. Int J Mol Sci,2018, 19 (11): 3672.
|
19 |
SHAO S, ZHAO X, ZHANG X, et al. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner [J]. Mol Cancer, 2015, 14 (1): 28.
|
20 |
VINSON K E, GEORGE D C, FENDER A W, et al. The Notch pathway in colorectal cancer [J]. Int J Cancer, 2016, 138 (8):1835-1842.
|
21 |
程少燕,李 峰,平 玉,等.抑制Notch1信号通路对CD8+ T细胞免疫检查点、功能及增殖的影响[J].郑州大学学报(医学版),2019,54(3):323-326.
|
22 |
TSANG R Y, Al-FAYEA T, AU H J. Cisplatin overdose: toxicities and management [J]. Drug Saf, 2009, 32 (12): 1109-1122.
|
23 |
WANG M, MA X, WANG J, et al. Pretreatment with the γ-secretase inhibit or DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling [J].Int J Oncol, 2014,44(4):1401-1409.
|
24 |
ZENG D, LIANG Y K, XIAO Y S, et al. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells [J]. Int J Cancer, 2020,147(2): 490-504.
|